CINCINNATI & SAN DIEGO--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), today announced an exclusive global license agreement with a wholly owned subsidiary of Gossamer Bio, Inc., GB004, Inc. (“Gossamer”), for the development and commercialization of Aerpio’s HIF-1 alpha stabilizer, AKB-4924, along with other related compounds. The arrangement combines Aerpio’s deep understanding of HIF biology with Gossamer’s experience in inflammation, immunology and inflammatory bowel disease (IBD) drug development. AKB-4924 (to be known as GB004) is an investigational hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilizer in development for IBD. Unlike other HIF stabilizers in clinical dev

SAN FRANCISCO, June 25, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced the treatment of the first patient in the Phase 1 clinical trial evaluating UBX0101 in moderate to severe osteoarthritis of the knee. “For many people, we believe that osteoarthritis is the main reason why it hurts to get old,” said Jamie Dananberg, M.D., chief medical officer at UNITY. “By designing a treatment to selectively eliminate senescent cells in the joints of patients diagnosed with painful osteoarthritis, our goal is to alter the otherwise disabling

-- Via Indigo Research Partners™, a network of 50+ of the largest US growers, Indigo has instrumented fields across the US to gather over a trillion data points each day and test hundreds of agricultural technologies over the next two years -- Open platform for agricultural research enables data-based agronomic & financial decision making and accelerates adoption of innovative technologies BOSTON, June 13, 2018 /PRNewswire/ -- Indigo Ag, Inc., a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces today the expansion of its innovation platform, Indigo Research PartnersTM. The platform, which was launched in 2017 as Indigo PartnersTM, involves collabor

(Bloomberg) -- Saudi Arabian Oil Co., the world’s biggest oil exporter, struck a deal to use a California startup’s chemical technology in new multi-billion-dollar crude-to-chemical factories. Saudi Aramco, as the oil giant is known, plans to employ Siluria Technologies Inc.’s process for converting natural gas left over from the crude-refining process into ethylene, the primary building block for plastics, according to a joint announcement by the companies on Wednesday. Terms of the deal were not disclosed. Siluria’s technology, known as oxidative methane coupling, is an alternative to the chemical industry’s traditional high-temperature method of processing gas, called cracking. Closely-he